Alberta Health Services Cross Cancer Institute

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 3 studies all time

What they study most

Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer, Metastatic Melanoma, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — Recruiting now
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed